BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32665038)

  • 1. Identification of potential crucial genes and key pathways in osteosarcoma.
    Liu J; Wu S; Xie X; Wang Z; Lei Q
    Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
    Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
    Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory network of differentially expressed genes in metastatic osteosarcoma.
    Yao P; Wang ZB; Ding YY; Ma JM; Hong T; Pan SN; Zhang J
    Mol Med Rep; 2015 Mar; 11(3):2104-10. PubMed ID: 25434727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential crucial genes and construction of microRNA-mRNA negative regulatory networks in osteosarcoma.
    Pan Y; Lu L; Chen J; Zhong Y; Dai Z
    Hereditas; 2018; 155():21. PubMed ID: 29760609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
    Fan H; Lu S; Wang S; Zhang S
    Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
    Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
    Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
    Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
    Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hub genes related to metastasis and prognosis of osteosarcoma and establishment of a prognostic model with bioinformatic methods.
    Fu Z; Sun G; Li J; Yu H
    Medicine (Baltimore); 2024 Jun; 103(23):e38470. PubMed ID: 38847690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics Analysis and Identification of Genes and Molecular Pathways Involved in Synovial Inflammation in Rheumatoid Arthritis.
    Xiong Y; Mi BB; Liu MF; Xue H; Wu QP; Liu GH
    Med Sci Monit; 2019 Mar; 25():2246-2256. PubMed ID: 30916045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting novel genes and pathways associated with osteosarcoma by using bioinformatics analysis.
    Dong B; Wang G; Yao J; Yuan P; Kang W; Zhi L; He X
    Gene; 2017 Sep; 628():32-37. PubMed ID: 28687333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
    He Y; Ma J; Ye X
    Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal DNA methylation may contribute to the progression of osteosarcoma.
    Chen XG; Ma L; Xu JX
    Mol Med Rep; 2018 Jan; 17(1):193-199. PubMed ID: 29115427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional analysis of differentially expressed genes related to metastatic osteosarcoma.
    Niu F; Zhao S; Xu CY; Chen L; Ye L; Bi GB; Tian G; Gong P; Nie TH
    Asian Pac J Cancer Prev; 2014; 15(24):10797-801. PubMed ID: 25605179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
    Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
    Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.